Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 1, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 3, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001711462-26-000015
Filed / recorded
Nov 3, 2026, 11:00 PM UTC
Added to OQRO
Nov 3, 2026, 11:05 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
First Tracks Biotherapeutics, Inc.
Issuer CIK
2091349
Ticker
TRAX
Reporting person
Paul F. Lizzul
Relationship
Officer
Officer title
Chief Medical Officer
Security
Common Stock
Table
Derivative (Table II)
Transaction date
Nov 1, 2026
Transaction code
A
Shares / units
42,500
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
42,500
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on November 1, 2026. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). Once an applicable Performance Metric has been met, the PSUs subject to such Performance Metric (an "Achieved PSU") shall vest as follows: 50% of the Achieved PSUs for each satisfied tranche shall vest on the one-year anniversary of the Certification Date of the achievement of the applicable Performance Metric, and the remaining 50% of the Achieved PSUs shall vest on the two-year anniversary of the applicable Certification Date.
(cont'd from Footnote 2) Notwithstanding the foregoing, all Achieved PSUs that have not previously vested pursuant to the vesting schedule will vest on December 15, 2030 (or, if a Share Price Target is achieved on December 15, 2030, vesting will occur on its Certification Date), subject to the Reporting Person's service to the Issue on each vesting date.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.